After her observership at the University of California, Irvine radiation oncology department, Dr. Mytsak educated her colleagues 
at the Prycarpathian Cancer Center medical conference.
She called to action to:
– embrace the fast adoption of clinical trial results into the clinic,
– place the patient in the center of the therapeutic process as an active rather than passive participant,
– consolidate the well-oiled team approach for streamlined and safer processes, and
– look towards the future of radiotherapy with decreasing treatment time and treatment fractions, decreasing irradiated volumes, thus, normal tissue toxicity using image guidance and adaptive technologies of IMRT/IGRT/SBRT.
All towards a desired result of a healthier, happier cancer patient.
“It was a very fruitful internship”, – concludes Lesya Mytsak, – “the acquired knowledge and acquired skills will help our radiology department to provide high-quality radiation treatment”.
Help Ukraine Group is proud of Dr. Mytsak’s achievements and will support her in her future endeavors of switching from Co-60 radiation therapy to linac-based IMRT.
